Search

everythinglearnresearchcommunity

for

Search:↓

Thymosin β4 helps with healing, inflammation, and organ protection.

SIG-1451 could be a promising new treatment for atopic dermatitis.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Strontium zinc silicate may help treat osteoporosis and muscle loss.

Hair changes could indicate neurological diseases and help monitor treatment.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Adalimumab may cause severe hair loss in some patients.

Trace element deficiencies may contribute to diffuse alopecia.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Higher RBP4 levels found in people with two types of hair loss.

Lower vitamin D levels are linked to more severe alopecia areata.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Vitamin D receptor gene changes don't affect alopecia areata risk.

High retinol intake may worsen hair loss in alopecia areata.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

Low Vitamin D receptor levels in hair follicles may contribute to alopecia areata.